Delivery Order SPE2DB22D9765-SPE2DB24FH0GH
Award Date
8/5/24
Potential Completion Date
8/26/24
Potential Value
$3.6K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $5,002.83 for the procurement of NEXPLANON 68 MG IMPLANTS. The contract is a firm fixed-price award with no set-aside designation, issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. DMS Pharmaceutical Group specializes in supplying a wide range of pharmaceutical products and medical supplies to the Department of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $41,024.40 under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC). The IDC, which has a ceiling value of up to $499,999,999, covers a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. This specific delivery order is for NEXPLANON 68 MG IMPLANTS, with a period of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the $499,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program. The contract is for the supply of NEXPLANON 68 MG IMPLANTS, a specialized pharmaceutical product, to support the medical supply needs of military health facilities. The contract is a firm fixed-price delivery order with a ceiling value of $6,943.10 and a...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides for the delivery of NEXPLANON 68 MG IMPLANTS to the Department of Defense (DoD) and Department of Veterans Affairs (VA) medical facilities. The firm fixed-price delivery order, valued at $4,288.14, was awarded on September 25, 2024, with an ultimate completion date of October 17, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $1,429.38. The award was made by the Defense Logistics Agency (DLA) under the SPE2DB program, which is a multi-year, single-award indefinite delivery contract (IDC) with a ceiling value of up to $499,999,999. The contract is for the delivery of 4566007817 NEXPLANON 68 MG IMPLANTS to support the recurring medical supply needs of...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the supply of NEXPLANON 68 MG IMPLANTS, with a ceiling value of $7,146.90 and a period of performance through September 27, 2024. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract has a firm fixed-price pricing type and is for the delivery of NEXPLANON 68 MG IMPLANTS, a pharmaceutical product, to support the recurring medical supply needs of U.S. Department of Defense (DoD) healthcare facilities. The contract has a ceiling value of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $8,576.28 for the supply of NEXPLANON 68 MG IMPLANTS. The award was made by the Defense Logistics Agency (DLA) under the SPE2DB program, which is an indefinite delivery contract (IDC) with a ceiling value of up to $499,999,999 that runs through December 31, 2025. DMS Pharmaceutical Group holds this single-award IDC to provide a comprehensive range of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The firm fixed-price delivery order, valued at $7,146.90, has an ultimate completion date of September 19, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications, including branded and generic...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a Firm Fixed Price delivery order worth $4,288.14 awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive device, with a performance period through October 21, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of pharmaceutical...